What’s Next: Nanoscopic Biological Computer for Cancer Treatment
A new nanoscopic biological computer kills cancer cells, spares healthy ones.
Progress Against Cancer
A new nanoscopic biological computer kills cancer cells, spares healthy ones.
Critics warn that lower nicotine content in the cigarettes may not translate into better odds of quitting.
Geriatric assessment minimizes toxic effects of treatment for older patients with advanced cancer.
Women who have been diagnosed with breast cancer are at greater risk for developing high blood pressure and diabetes, common risk factors for heart disease.
Researchers find that when treating metastatic melanoma, timing is everything.
Many women are being diagnosed with cervical cancer, despite the availability of tools to prevent and diagnose the disease. Black and Hispanic women and low-income and rural populations are especially vulnerable.
New therapies are being developed to attack a previously untreatable cancer mutation.
American Cancer Society reacts to Supreme Court decision, and more from the week in cancer news.
The CAR T-cell therapy lisocabtagene maraleucel was approved for the second-line treatment of certain patients with large B-cell lymphoma. The U.S. Food and Drug Administration (FDA) has approved lisocabtagene maraleucel (Breyanzi) for the second-line...
Ibrutinib, a small molecule inhibitor of B-cell proliferation, was approved for pediatric patients with chronic graft-versus-host disease. The U.S. Food and Drug Administration (FDA) has approved ibrutinib (Imbruvica) for pediatric patients 1 year of...
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More